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Abstract
Background: According to previous meta-analyses, coffee consumption reduces the risk of type 2 diabetes mellitus.
However, the underlying mechanism remains unknown. Whether caffeine, the key ingredient in coffee, has a beneficial
effect on the glycemic homeostasis and the anti-diabetic effect is particularly controversial. The aim of this study was to
summarize the effect of acute caffeine ingestion on insulin sensitivity in healthy men.
Methods: A comprehensive literature search for papers published before April 2016 was conducted in EMBASE,
PubMed, and Cochrane Library databases. Randomized controlled trials (RCTs) that investigated the effect of
caffeine on insulin sensitivity in healthy humans without diabetes were included. A random effects meta-analysis
was conducted using Review Manager 5.3.
Results: The search yielded 7 RCTs in which caffeine intake was the single variant. Compared with placebo,
caffeine intake significantly decreased the insulin sensitivity index, with a standardized mean difference of −2.06
(95% confidence interval −2.67 to −1.44, I2 = 49%, P for heterogeneity = 0.06).
Conclusion: Acute caffeine ingestion reduces insulin sensitivity in healthy subjects. Thus, in the short term, caffeine
might shift glycemic homeostasis toward hyperglycemia. Long-term trials investigating the role of caffeine in the
anti-diabetic effect of coffee are needed.
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Introduction
The worldwide prevalence of type II diabetes has doubled
in the previous two decades; this, in combination with the
high disability and mortality rates has contributed to the
serious effects of type II diabetes on human health [1]. A
systematic analysis of health examination surveys and
epidemiological studies estimated that the overall age-
standardized incidence of diabetes was approximately
9.2% for women and 9.8% for men [2]. Prevention of
diabetes through the adoption of healthy dietary habits
is particularly important for the effective management
of hyperglycemia [3, 4].
Coffee is one of the most widely consumed beverages
globally. Different amounts of coffee are habitually
consumed to different countries or by people of different
races; residents of the Netherlands and Finland are
among the largest coffee drinkers, and Caucasians tend
to consume more coffee than other races. Evidence is
accumulating that habitual coffee consumption is linked
to a reduced incidence of type II diabetes [5], and epi-
demiological studies conducted with people of different
races have shown that coffee consumption is inversely
correlated with the incidence of type II diabetes [6–16].
Importantly, higher consumption of all coffee products,
caffeinated coffee, and decaffeinated coffee was associated
with a lower risk of total mortality [17, 18].
Various mechanisms have been proposed regarding
the protective effect of long-term coffee consumption
against type II diabetes. Kemfp et al. reported that coffee
consumption might have beneficial effects on subclinical
inflammation and high-density lipoprotein cholesterol [19].
Kagami et al. showed that caffeine protects pancreatic beta
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cells against streptozocin toxicity [20]. Nevertheless,
whether caffeine alone influences glycemic control, which
is closely linked with diabetes-related micro- or macro-
vascular complications [21], remains unknown; this know-
ledge would provide insight into the role of caffeine in the
putative relationship between coffee consumption and the
risk of diabetes.
Caffeine, a mildly psycho-active chemical, is one of the
most commonly consumed “drugs”, with an average daily
individual intake of approximately 300 mg from dietary
sources such as coffee, tea, soft drinks, chocolate, and
energy drinks, among which coffee is the predominant
source. Caffeine is one of the main components in cof-
fee and is also used as an additive in more than 60% of
available soft drinks [22]. Tea and other beverages that
contain caffeine also reportedly protect against type II
diabetes [23]. However, the underlying mechanism re-
mains unclear, and the results of bedside and bench-based
research are controversial [19, 24, 25]. Because type II
diabetes is characterized by impaired insulin sensitivity,
caffeine might play an important role in the protective
effect of coffee against type II diabetes.
The current meta-analysis aimed to investigate the ef-
fect of caffeine alone on insulin sensitivity in healthy
subjects. Whitehead et al. conducted a systematic review
of randomized controlled trials (RCTs) of the effects of
caffeine on glycemic control in people with diabetes melli-
tus [26]. However, the implications of the results might be
limited, because the beneficial effect of coffee consump-
tion for diabetes is supposedly more preventive than heal-
ing. Hence, data from healthy subjects are needed to
investigate the protective effect of coffee against diabetes.
Ding et al. conducted a systematic review of the associ-
ation between caffeinated/decaffeinated coffee consump-
tion and the risk of type II diabetes [18]. Similarly, Jiang et
al. conducted a meta-analysis of prospective studies of the
relationship between coffee/caffeine intake and the inci-
dence of type II diabetes [17]. There is some discrepancy
between these reviews regarding the effect of caffeine on
diabetes prevalence. Because very few systematic reviews
and meta-analyses have been conducted for RCTs on the
association between caffeine alone and glycemic control in
healthy subjects, the current meta-analysis could be sig-
nificant for clarifying the inverse association between
coffee consumption and type II diabetes.
Methods
Search strategy
The PubMed (1960 to April 2016; http://www.ncbi.nlm.
nih.gov/pubmed/), EMBASE (1980 to April 2016; http://
www.embase.com/), and Cochrane Library (1985 to April
2016; http://www.cochrane.org/) databases were searched
for RCTs that examined the effects of caffeine on insulin
sensitivity in healthy humans. The following key words in
the title/abstract were used: caffeine and glucose, glycemic
control, insulin, or insulin sensitivity. The search was re-
stricted to human clinical trials. In addition, the reference
lists from selected reports were reviewed for further
relevant studies. The systematic review was planned,
conducted, and reported according to the PRISMA state-
ment [27]. The review protocol was registered in the
PROSPERO International Prospective Register of System-
atic Reviews (CRD42016041224).
Study selection
The following criteria were used for study selection: 1)
subjects consumed a caffeine-containing beverage be-
fore ≥2-week washout during which no caffeine-containing
products were consumed; 2) the study was an RCT with
a parallel or crossover design conducted with healthy
humans; 3) insulin sensitivity was calculated using stand-
ard deviations; 4) the only variant between the experimen-
tal and control groups was caffeine administration. The
quality of the selected studies, regarding the risk of bias,
was assessed using the computer program Review Man-
ager (RevMan), Version 5.3 (The Nordic Cochrane Centre,
The Cochrane Collaboration, Copenhagen).
Of the 366 studies identified in the initial search, the
first review excluded 101 publications for not being rele-
vant or a duplicate study, the second review excluded 247
publications because they did not describe human clinical
trials, and the third review excluded 11 publications that
did not include appropriate insulin sensitivity data. There-
fore, 7 studies involving 70 participants were included
(Fig. 1). The selected placebo was reviewed to assure that
caffeine intake was the only variant. One study by Green-
berg et al. [28] used two pairs of treatments: caffeine vs.
placebo and caffeinated coffee vs. decaffeinated coffee.
Only data from the latter pair were included because
coffee consumption occurs more frequently than ad-
ministration of pure caffeine in daily life.
Data extraction
Study features, including authors & publication year, sam-
ple size (male: female), study design, and other relevant
information were collected, in addition to the insulin
sensitivity index (Table 1).
Statistical analysis
The current meta-analysis was performed using the com-
puter program RevMan 5.3. Copenhagen. Heterogeneity
between trial results was tested using a standard χ2 test.
The I2 parameter was used to quantify any inconsistency,
and I2 > 50% was considered to represent substantial het-
erogeneity [29]. Because of the different methodologies
adopted by individual researchers, a random-effects model
was used to assess the standardized mean differences
(SMD) and 95% confidence intervals (CIs) in insulin
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sensitivity. Forest plots were generated to illustrate the
study-specific effect sizes and a 95% CIs. Data extrac-
tion was independently conducted by the two co-first
authors, with disagreements resolved by consensus.
Results
Study characteristics
The trial characteristics are shown in Table 1. The sam-
ples varied in size from 7 to 12 subjects. All the studies
were of a single- or double-blind, randomized crossover
design. Six of the seven trials [28, 30–34] included male
subjects, and the sample in the remaining trial [35] was
50% men. All of the subjects had no history of diabetes
or other metabolic diseases. All of the publications, except
those by Petrie et al. [31] and Thong et al. [30], mentioned
that the subjects were non-smokers. The subjects in 6
studies [28, 30, 32–35] were lean (BMI ≤ 25 kg/m2). The
remaining trial conducted by Petrie et al. [31] examined
the effects of caffeine ingestion and nutrition/exercise
intervention in obese subjects (BMI 34.0 ± 1.0 kg/m2). All
of the trials used a washout time of ≥ 48 h. The most
commonly used caffeine dose was 5 mg caffeine/kg body
weight [30, 31, 33, 34], while Battram et al. [32] used
4.45 mg/kg, Greenberg et al. [28] used 6 mg/kg and
Keijzer used 3 mg/kg.
Data quality and risk of bias
All of the included studies used a randomized, crossover
design, reducing selection bias. However, the studies did
not describe allocation concealment. In the study by
Greenberg et al., the researchers were blinded to the
participants’ group. Because the researchers assigning
the tested beverages were different from those who col-
lected and analyzed the outcome data, the blinding of
participants and personnel was rated unclear in relation
to performance bias (Fig. 2a and b). In contrast, the
principle researchers were blinded to all of the experimen-
tal treatments, but the subjects were not blinded to the
Fig. 1 Selection process of the identified articles
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cereal treatment in the study conducted by Moisey et al.
[33]. Therefore, the knowledge that they were consuming
cereal with a low glycemic index could have resulted in a
substantial placebo effect; as a result, the risk of perform-
ance bias was rated as high. There were no specific state-
ments about the blinding of the outcome assessment,
resulting in unclear risk of detection bias. The measured
outcomes in each included study were determined in the
trial planning stage, and all but 2 reported all the pre-
designed measurements, resulting in no reporting bias.
No other bias was detected in the 7 studies.
Caffeine consumption and insulin sensitivity in healthy
subjects
Figure 3 demonstrates the effect of caffeine consumption
on insulin sensitivity in healthy subjects, as determined
in the meta-analysis [28, 30–36]. The included studies
adopted two different strategies to determine the insulin
Fig. 2 Risk of bias assessment tool: (a) risk of bias graph; (b) risk of bias summary. Across trials, information is either from trials at a low risk of bias
(green), at an unclear risk of bias (yellow), or at a high risk of bias (red)
Fig. 3 Forest plot showing the pooled standardized mean difference (SMD) and 95% confidence interval (CI) for insulin sensitivity for 7 randomized
controlled trials. For each study of caffeine, the shaded square represents the point estimate of the intervention effect. The horizontal line joins the
lower and upper limits of the 95% CI of these effects. The area of the shaded square reflects the relative weight of the study in the respective
meta-analysis. The diamond at the bottom of the graph represents the pooled SMD with the 95% CI for the seven trials. Experimental: caffeine
group; Control: control group; I2: Inconsistency
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sensitivity index: a hyperinsulinemic-euglycemic glucose
clamp and/or the Matsuda and DeFronzo equation [37]
after an oral glucose tolerance test (OGTT). Keijzers et al.
[35] was the first to use a hyperinsulinemic-euglycemic
glucose clamp to calculate the insulin sensitivity in 12
non-smoking, lean, normotensive, healthy volunteers.
Owing to the different methodologies, we used the SMD
to measure the effect, inverse variance as the statistical
method, and random effects as the analytic model.
All trials consistently reported a reduction in insulin
sensitivity with caffeine consumption. Compared with
placebo, caffeine intake significantly decreased the insu-
lin sensitivity index (SMD −2.06, 95% CI −2.67 to −1.44,
I2 = 49%, P for heterogeneity = 0.07). The trial performed
by Petrie et al. [31] generated two sets of data for the
effect of caffeine ingestion: before and after a nutrition/
exercise intervention. The intervention significantly de-
creased body weight and percentage body fat. Subsequently,
the insulin sensitivity index markedly increased from 4 ± 1
(caffeine) and 5 ± 1 (placebo) to 6 ± 1 (caffeine) and 8 ± 1
(placebo). We included the data after the nutrition and ex-
ercise intervention because the heterogeneity was lower, as
compared with the other included studies.
The epidemiological evidence for an inverse associ-
ation between coffee and type II diabetes is strong, while
evidence is accumulating that acute caffeine intake might
impair glucose metabolism. Therefore, the effect of decaf-
feinated coffee on glycemic control was tested by many
scientists. Greenberg et al. [28] reported acutely impaired
glucose metabolism by decaffeinated coffee in healthy
young men. However, Battram et al. [32] found an acute
enhancement of glucose metabolism by ground decaf-
feinated coffee, while Johnston et al. [38], Tom [39], and
Van Dijk et al. [40] found no acute effect on glucose
metabolism by instant decaffeinated coffee.
Elevated glucose and insulin response after caffeine intake
A 2-h OGTT is commonly used by researchers to in-
vestigate glucose homeostasis. During the screening
of the literature, we found another set of 7 studies
[31–33, 36, 38, 41, 42] that explore the effect of caffeine on
glucose modulation, reporting the area under the curve
(AUC) for glucose and insulin. Pizzol et al. [42] tested the
effects of 200 mg oral caffeine on glucose tolerance; during
a 4-h OGTT, the glycemic curve was normal in both the
caffeine and placebo groups until the second hour, but
shifted towards the right in the caffeine group in the 2nd,
3rd, and 4th hours, compared with placebo. The AUC was
separated into two parts: initial phase (≤2nd hour) and ter-
minal phase (3rd and 4th hours). Unfortunately, the hetero-
geneity of these studies was too large to effectively perform
a meta-analysis (I2 = 87%, P < 0.001); however, all of the
studies consistently reported elevated AUCs for both
glucose and insulin.
Discussion
In the current meta-analysis, acute administration of caf-
feine reduced insulin sensitivity. Therefore, the inverse
association between coffee and diabetes was not attrib-
uted to enhanced glucose control.
The global difference in caffeine intake could stem
from multiple reasons, including different dietary habits.
Residents of Western countries tend to drink more coffee,
while residents of Eastern countries tend to drink more
tea. Genetic reasons could also contribute; in a recent
publication in Scientific Reports, a team of researchers re-
ported that participants in Italy and the Netherlands with
the genetic variant PDSS2 tended to drink one fewer cup
of coffee per day than those without the variant [43]. Fur-
ther analysis revealed PDSS2 gene expression appears to
inhibit the body’s ability to break down caffeine [43].
Therefore, people with this variant would require less cof-
fee for the same caffeine effect because the caffeine would
be available in their system for a longer time.
Caffeine (1, 3, 7-trimethylxanthine) is a derivative of
methylxanthine, a potentially antagonizing adenosine
receptor. Data from animal models or in-vitro studies
indicate that methylxanthines are involved in insulin-
mediated glucose metabolism in adipose and muscle tis-
sue [44, 45], implying a close link between caffeine and
glycemic control. However, caffeine might also regulate
glucose metabolism by reducing the intracellular energy
status in an insulin-independent manner [46].
The current meta-analysis could be of some significance
for clarifying the relationship between caffeine consump-
tion and diabetes. In a systematic review, Ding et al. com-
pared the trends of the association between caffeinated/
decaffeinated coffee and the risk of type II diabetes. The
authors reported a protective effect of decaffeinated coffee
against diabetes, indicating that components of coffee
other than caffeine are responsible for the putative benefi-
cial effect. However, without data from those who con-
sume pure caffeine, the aforementioned conclusion could
be without basis. In contrast, in the meta-analysis by
Jiang et al., which explored the association between coffee/
caffeine intake and type II diabetes incidence, the dose-
response data suggested that incremental caffeine intake
had a stronger beneficial effect for type II diabetes than
coffee intake, and caffeine intake provided greater protec-
tion than decaffeinated coffee intake. The results implied
an indispensable role of caffeine in the protective effect
against diabetes. The current meta-analysis demonstrated
that acute caffeine ingestion was associated with reduced
insulin sensitivity, implying that the long-term benefit of
caffeine intake could be attributed to better management
of calorie intake in coffee drinkers.
This review has some limitations. Restricted by the selec-
tion strategy, the selected trials all had a relatively small
sample size. Nevertheless, the current results are supported
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by plenty of indirect evidence. Thong et al. demonstrated
that caffeine induces insulin-stimulated glucose uptake in
human skeletal muscle [47]. In addition, the antagonistic
effects of caffeine on insulin in vivo are reportedly medi-
ated by elevated epinephrine levels [30]. Furthermore,
chronic caffeine intake reverses aging-induced insulin
resistance in rats [48], highlighting the beneficial effect
of long-term caffeine intake. Hence, further long-term
RCTs of caffeine intake are needed to elucidate the under-
lying mechanism of the inverse association between coffee
consumption and type II diabetes.
The significance of caffeine in diabetes is noticeable in
other areas. For patients with diabetes, it is vital to be
aware of decreasing blood glucose levels, because a lack
of awareness about hypoglycemia is dangerous. The study
by Debrah et al. found that caffeine induces a sustained de-
crease in middle cerebral artery velocity and augments
sympathoadrenal and symptomatic responses during
moderate hypoglycemia, representing a potentially use-
ful treatment for patients with diabetes that have diffi-
culty recognizing the onset of hypoglycemia [49].
Conclusions
The current meta-analysis demonstrated that acute ad-
ministration of caffeine attenuates insulin sensitivity in
healthy subjects. It is imperative that additional evidence
about the chronic effect of caffeine be collected to better
understand the role of coffee in the development and
prevention of type 2 diabetes.
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